Article metrics

Download PDFPDF

Extended report
Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding to methotrexate

 

Online download statistics by month:

Online download statistics by month: December 2017 to April 2025

AbstractFullPdf
Dec 2017902918195
Jan 2018714756301
Feb 201810461046260
Mar 2018752757175
Apr 201842742886
May 201832332749
Jun 201820120742
Jul 201814514328
Aug 201813313330
Sep 201812912929
Oct 201814614628
Nov 201818518642
Dec 201814714728
Jan 201912011625
Feb 2019969528
Mar 2019717122
Apr 2019484423
May 2019615924
Jun 2019453925
Jul 2019908529
Aug 2019554729
Sep 2019614018
Oct 2019776646
Nov 2019343214
Dec 2019383722
Jan 2020595723
Feb 2020505014
Mar 2020464615
Apr 2020383532
May 2020453617
Jun 2020444313
Jul 2020474630
Aug 2020363516
Sep 2020333014
Oct 2020484020
Nov 2020565118
Dec 2020484117
Jan 2021292412
Feb 2021292811
Mar 2021363511
Apr 2021242210
May 2021282622
Jun 2021242211
Jul 2021262222
Aug 202132289
Sep 2021363412
Oct 2021443621
Nov 2021292819
Dec 2021353114
Jan 2022312914
Feb 202221203
Mar 2022655919
Apr 2022343315
May 2022555520
Jun 2022403810
Jul 2022383611
Aug 202244437
Sep 2022464735
Oct 2022545116
Nov 202223239
Dec 2022292813
Jan 2023363614
Feb 2023585610
Mar 202328266
Apr 2023302920
May 2023323015
Jun 202332306
Jul 2023333318
Aug 202331297
Sep 202318195
Oct 2023565213
Nov 202361619
Dec 2023898856
Jan 20244837104
Feb 202441417
Mar 2024414019
Apr 2024615912
May 2024696616
Jun 2024292619
Jul 2024424111
Aug 202442407
Sep 2024545217
Oct 2024737012
Nov 2024434211
Dec 202442415
Jan 202533367
Feb 2025363610
Mar 202525256
Apr 202526269
Total865785292624